Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 121
Filter
1.
Nutr Metab Cardiovasc Dis ; 32(9): 2061-2073, 2022 09.
Article in English | MEDLINE | ID: mdl-35850749

ABSTRACT

BACKGROUND AND AIMS: This study aims to examine the associations of food portion size (PS) with markers of insulin resistance (IR) and clustered of metabolic risk score in European adolescents. METHODS: A total of 495 adolescents (53.5% females) from the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) study were included. The association between PS from food groups and homeostasis model assessment of insulin resistance (HOMA-IR) index, VO2 max, and metabolic risk score was assessed by multilinear regression analysis adjusting for several confounders. Analysis of covariance (ANCOVA) was used to determine the mean differences of food PS from food groups by HOMA-IR cutoff categories by using maternal education as a covariable. RESULTS: Larger PS from vegetables in both gender and milk, yoghurt, and milk beverages in males were associated with higher VO2 max, while larger PS from margarines and vegetable oils were associated with lower VO2 max (p < 0.05). Males who consumed larger PS from fish and fish products; meat substitutes, nuts, and pulses; cakes, pies, and biscuits; and sugar, honey, jams, and chocolate have a higher metabolic risk score (p < 0.05). Males with lower HOMA-IR cutoff values consumed larger PS from vegetables, milk, yoghurt, and milk beverages (p < 0.05). Females with lower HOMA-IR cutoff values consumed larger PS from breakfast cereals, while those with higher HOMA-IR cutoff values consumed larger PS from butter and animal fats (p = 0.018). CONCLUSION: The results show that larger PS from dairy products, cereals, and high energy dense foods are a significant determinant of IR and VO2 max, and larger PS from food with higher content of sugar were associated with higher metabolic risk score.


Subject(s)
Insulin Resistance , Metabolic Syndrome , Dairy Products , Female , Humans , Male , Portion Size , Sugars
2.
J Nutr Health Aging ; 26(4): 360-366, 2022.
Article in English | MEDLINE | ID: mdl-35450992

ABSTRACT

BACKGROUND: The ageing process can be influenced by energy intake and different macronutrients within the diet. The soluble form of the α-Klotho gene (called S-Klotho) is widely considered as a powerful anti-ageing biomarker. OBJECTIVE: To analyze the association of energy, dietary energy density and macronutrient intake with S-Klotho plasma levels in middle-aged sedentary adults. METHODS: A total of 72 (52.8% women) middle-aged sedentary adults (53.7 ± 5.2 years old) participated in the study. Energy and macronutrients intake (i.e. fat, carbohydrate and protein) were assessed using three non-consecutive 24-h recalls. S-Klotho plasma levels were measured in the Ethylenediaminetetraacetic acid (EDTA) plasma using a solid-phase sandwich enzyme-linked immunosorbent assay. RESULTS: No association was observed between energy, dietary energy density or macronutrient intake and S-Klotho plasma levels in men (all P≥ 0.1). We found an inverse association between energy, protein and carbohydrate intake with S-Klotho plasma levels in women (all P≤0.043), which disappeared after controlling for age, lean mass index and sedentary time. An inverse association was observed between dietary energy density and S-Klotho plasma levels in women after controlling for covariates (all P≤0.05). CONCLUSION: In summary, the present study showed an inverse association of dietary energy density with S-Klotho plasma levels in middle-aged women. In addition, our data suggest that the associations between energy and macronutrient intake could be highly dependent on lean mass and sedentary time.


Subject(s)
Glucuronidase , Klotho Proteins , Carbohydrates , Cross-Sectional Studies , Dietary Carbohydrates , Dietary Fats , Eating , Energy Intake , Female , Humans , Male , Middle Aged , Nutrients
3.
Neurologia (Engl Ed) ; 35(4): 245-251, 2020 May.
Article in English, Spanish | MEDLINE | ID: mdl-32364119

ABSTRACT

INTRODUCTION: SARS-CoV-2 was first detected in December 2019 in the Chinese city of Wuhan and has since spread across the world. At present, the virus has infected over 1.7 million people and caused over 100 000 deaths worldwide. Research is currently focused on understanding the acute infection and developing effective treatment strategies. In view of the magnitude of the epidemic, we conducted a speculative review of possible medium- and long-term neurological consequences of SARS-CoV-2 infection, with particular emphasis on neurodegenerative and neuropsychiatric diseases of neuroinflammatory origin, based on the available evidence on neurological symptoms of acute SARS-CoV-2 infection. DEVELOPMENT: We systematically reviewed the available evidence about the pathogenic mechanisms of SARS-CoV-2 infection, the immediate and lasting effects of the cytokine storm on the central nervous system, and the consequences of neuroinflammation for the central nervous system. CONCLUSIONS: SARS-CoV-2 is a neuroinvasive virus capable of triggering a cytokine storm, with persistent effects in specific populations. Although our hypothesis is highly speculative, the impact of SARS-CoV-2 infection on the onset and progression of neurodegenerative and neuropsychiatric diseases of neuroinflammatory origin should be regarded as the potential cause of a delayed pandemic that may have a major public health impact in the medium to long term. Cognitive and neuropsychological function should be closely monitored in COVID-19 survivors.


Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/complications , Cytokine Release Syndrome/etiology , Cytokines/physiology , Mental Disorders/etiology , Neurodegenerative Diseases/etiology , Pandemics , Pneumonia, Viral/complications , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/physiopathology , Cytokine Release Syndrome/physiopathology , Cytokine Release Syndrome/psychology , Disease Progression , Humans , Immune System/physiopathology , Immune System/virology , Inflammation , Inflammation Mediators/physiology , Mental Disorders/epidemiology , Models, Immunological , Models, Neurological , Neurodegenerative Diseases/epidemiology , Neuroimmunomodulation/physiology , Pneumonia, Viral/epidemiology , Pneumonia, Viral/physiopathology , Public Health , SARS-CoV-2 , Time Factors
4.
J Hum Nutr Diet ; 33(1): 86-97, 2020 02.
Article in English | MEDLINE | ID: mdl-31270896

ABSTRACT

BACKGROUND: Exercise could influence energy and macronutrient intake, which could have an important role on body composition changes in response to exercise. The present study aimed to investigate the effects of different training modalities in energy and macronutrient intake, and whether changes in energy and macronutrient intake influences changes in body composition in response to different training modalities. METHODS: A 12-week randomised controlled trial was conducted. Eighty middle-aged sedentary adults were randomised to: (i) a control group; (ii) physical activity recommendation from the World Health Organization; (iii) high-intensity interval training; and (iv) whole-body electromyostimulation training. Dietary intake was assessed using the average of three 24-h recalls. RESULTS: High-intensity interval training and whole-body electromyostimulation training groups showed lower fibre intake and higher dietary energy density. Our results showed a negative association was found between changes in energy intake and changes in lean mass index. No association was found between changes in protein intake and changes in lean mass index. CONCLUSIONS: In conclusion, we observed a higher dietary energy density and lower fibre intake in high-intensity training groups.


Subject(s)
Eating/physiology , Energy Intake/physiology , Exercise Movement Techniques/methods , Exercise/physiology , Sedentary Behavior , Aged , Body Mass Index , Diet Surveys , Dietary Fiber/analysis , Dietary Proteins/analysis , Electric Stimulation Therapy/methods , Female , High-Intensity Interval Training/methods , Humans , Male , Middle Aged
5.
J Sports Sci ; 37(19): 2175-2183, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31164040

ABSTRACT

This study aimed to investigate the effects of different training modalities on the soluble Klotho (S-Klotho) plasma levels in sedentary middle-aged adults. A total of 74 middle-aged adults (53.4 ± 5.0 years old; 52.7% women) were enrolled in the FIT-AGEING study. We conducted a 12-week randomised controlled trial. The participants were randomly assigned to 4 different groups: (i) a control group (no exercise), (ii) a physical activity recommendation from the World Health Organization group (PAR), (iii) a high intensity interval training group (HIIT), and (iv) a high intensity interval training group adding whole-body electromyostimulation training group (HIIT-EMS). S-Klotho plasma levels, anthropometric measurements, and body composition variables were measured before and after the intervention programme. All exercise training modalities induced an increase in the S-Klotho plasma levels (all P ≤ 0.019) without statistical differences between them (all P ≥ 0.696). We found a positive association between changes in lean mass index and changes in the S-Klotho plasma levels, whereas a negative association was reported between changes in fat mass outcomes and changes in the S-Klotho plasma levels after our intervention study. In conclusion, our results suggest that the link between exercise training and the increase in S-Klotho plasma levels could be mediated by a decrease of fat mass and an increase of lean mass.


Subject(s)
Electric Stimulation , Exercise/physiology , Glucuronidase/blood , High-Intensity Interval Training/methods , Sedentary Behavior , Body Fat Distribution , Body Mass Index , Female , Humans , Klotho Proteins , Male , Middle Aged
6.
Biotechnol Prog ; 34(6): 1314-1334, 2018 11.
Article in English | MEDLINE | ID: mdl-30009567

ABSTRACT

Several of the over 200 known species of Agave L. are currently used for production of distilled beverages and biopolymers. The plants live in a wide range of stressful environments as a result of their resistance to abiotic stress (drought, salinity, and extreme temperature) and pathogens, which gives the genus potential for germplasm conservation and biotechnological applications that may minimize economic losses as a result of the global climate change. However, the limited knowledge in the genus of genome structure and organization hampers development of potential improved biotechnological applications by means of genetic manipulation and biocatalysis. We reviewed Agave and plant sequences in the GenBank NCBI database for identifying genes with biotechnological potential for fermentation, bioenergy, fiber improvement, and in vivo plant biopolymer production. Three-dimensional modeling of enzyme structures in plant accessions revealed structural differences in sucrose 1-fructosyltransferase, fructan 1-fructosyltransferase, fructan exohydrolase (1-FEH), cellulose synthase (CES), and glucanases (EGases) with possible effects in fructan, sugar, and biopolymer production. Although the coding genes of FEH and enzymes involved in biopolymer production (CES, sucrose synthase, and EGases) remain unidentified in Agave L., our results could aid isolation of such genes in Agave. By comparing nucleotide and amino acid sequences in accessions of Agave and other plants, knowledge may be gained about transcriptional regulation and enzymatic activity factors. Future study is needed of biotechnological application of Agave genes for crop breeding aided by genetic engineering and biocatalysis. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 34:1314-1334, 2018.


Subject(s)
Agave/metabolism , Biocatalysis , Biopolymers/metabolism , Biotechnology/methods , Fermentation/physiology
7.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(8): 406-410, 2018 Aug.
Article in English, Spanish | MEDLINE | ID: mdl-29807845

ABSTRACT

CASE REPORT: A 45-year-old man was diagnosed with malaria with neurological involvement. Two months later he referred metamorphopsia in the left eye. Malarial retinopathy was observed in the fundus examination. The Optic Coherence Tomography (OCT) of the macula showed parafoveal pigment epithelium detachment (DEP). Specific anti-malarial treatment was initiated, with the disappearance of the retinopathy being observed. DISCUSSION: Plasmodium falciparum is responsible for the retinopathy in neurological malaria. A funduscopic examination and macular OCT should be performed in these patients, as it is associated with a higher mortality when there is a retinal involvement.


Subject(s)
Malaria, Cerebral/complications , Malaria, Falciparum/complications , Retinal Detachment/etiology , Retinal Pigment Epithelium/pathology , Antimalarials/therapeutic use , Chad , Doxycycline/therapeutic use , Erythrocytes/parasitology , Fluorescein Angiography , Humans , Malaria, Cerebral/drug therapy , Malaria, Falciparum/drug therapy , Male , Middle Aged , Prednisone/therapeutic use , Quinidine/analogs & derivatives , Quinidine/therapeutic use , Quinine/therapeutic use , Retinal Detachment/diagnostic imaging , Retinal Detachment/drug therapy , Retinal Detachment/pathology , Retinal Hemorrhage/etiology , Retinal Pigment Epithelium/diagnostic imaging , Tomography, Optical Coherence , Travel-Related Illness
9.
Clin Rheumatol ; 37(4): 999-1009, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29214548

ABSTRACT

The objective of the study is to determine the importance of the mode of onset as prognostic factor in systemic sclerosis (SSc). Data were collected from the Spanish Scleroderma Registry (RESCLE), a nationwide retrospective multicenter database created in 2006. As first symptom, we included Raynaud's phenomenon (RP), cutaneous sclerosis, arthralgia/arthritis, puffy hands, interstitial lung disease (ILD), pulmonary arterial hypertension (PAH), and digestive hypomotility. A total of 1625 patients were recruited. One thousand three hundred forty-two patients (83%) presented with RP as first symptom and 283 patients (17%) did not. Survival from first symptom in those patients with RP mode of onset was higher at any time than those with onset as non-Raynaud's phenomenon: 97 vs. 90% at 5 years, 93 vs. 82% at 10 years, 83 vs. 62% at 20 years, and 71 vs. 50% at 30 years (p < 0.001). In multivariate analysis, factors related to mortality were older age at onset, male gender, dcSSc subset, ILD, PAH, scleroderma renal crisis (SRC), heart involvement, and the mode of onset with non-Raynaud's phenomenon, especially in the form of puffy hands or pulmonary involvement. The mode of onset should be considered an independent prognostic factor in systemic sclerosis and, in particular, patients who initially present with non-Raynaud's phenomenon may be considered of poor prognosis.


Subject(s)
Arthralgia/etiology , Hypertension, Pulmonary/etiology , Lung Diseases, Interstitial/etiology , Raynaud Disease/etiology , Scleroderma, Systemic/diagnosis , Adult , Aged , Female , Humans , Male , Middle Aged , Prognosis , Registries , Retrospective Studies , Scleroderma, Systemic/complications , Scleroderma, Systemic/physiopathology , Severity of Illness Index , Symptom Assessment
10.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(1): 42-46, 2018 Jan.
Article in English, Spanish | MEDLINE | ID: mdl-28506716

ABSTRACT

CASE REPORTS: Three clinical cases are presented of MEK retinopathy associated with the combination of cobimetinib and vemurafenib characterised by alteration of the retinal pigment epithelium and neurosensory detachment. Two of the cases conserved the vision of the unit, and the third developed a large bilateral neurosensory detachment with final visual acuity of 0.6 for the right eye and 0.1 for the left one. DISCUSSION: The new therapeutic strategies against metastatic cutaneous melanoma condition the appearance of alterations of the pigmentary epithelium of the retina with serous detachments, leading to close monitoring with macular optical coherence tomography.


Subject(s)
Antineoplastic Agents/adverse effects , Azetidines/adverse effects , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Piperidines/adverse effects , Retinal Diseases/chemically induced , Vemurafenib/adverse effects , Azetidines/therapeutic use , Female , Humans , Male , Melanoma/drug therapy , Melanoma/secondary , Middle Aged , Piperidines/therapeutic use , Vemurafenib/therapeutic use
11.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(3): 139-142, 2018 Mar.
Article in English, Spanish | MEDLINE | ID: mdl-28882395

ABSTRACT

CASES REPORTS: Three myopic components of a same family came for study because presented severely degraded vitreous, equatorial membranes, retinal pigment epithelium hyperplasia, vascular sheathed and sclerosis of peripheral predominance. A genetic study confirmed the diagnosis of Stickler syndrome with a variant in the mutation of the COL2A1 gene. DISCUSSION: Stickler's syndrome should be suspected in families with a characteristic phenotype with vitreous syneresis and alterations in the retina, but there may be genetic variants that do not express the classic phenotype.


Subject(s)
Arthritis/genetics , Connective Tissue Diseases/genetics , Hearing Loss, Sensorineural/genetics , Retinal Detachment/genetics , Adolescent , Adult , Arthritis/diagnostic imaging , Connective Tissue Diseases/diagnostic imaging , Female , Genetic Variation , Hearing Loss, Sensorineural/diagnostic imaging , Humans , Male , Pedigree , Phenotype , Retinal Detachment/diagnostic imaging
12.
Eur Ann Allergy Clin Immunol ; 49(6): 281-283, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29249137

ABSTRACT

SUMMARY: We report the case of a 36-year-old male pharmaceutical laboratory worker. On handling Spagulax® sachets whose content is a laxative called Plantago ovata, he immediately presented rhinoconjunctivitis. Methods. Specific allergy study included SDS-PAGE with Western Blot and specific nasal challenge to Plantago ovata extract. Results. Prick by prick for Spagulax® was negative. Total IgE: 126.5 U/mL. Western Blot recognized two proteins of 15 and 20 kDa in the extract of Plantago ovata and three proteins of 15, 18 and 50 kDa in the extract of Plantago lanceolata. Conclusions. We present a case of occupational allergy due to inhalation of and/or contact with Plantago ovata seeds.


Subject(s)
Conjunctivitis, Allergic/chemically induced , Drug Hypersensitivity/immunology , Laxatives/adverse effects , Occupational Diseases/immunology , Occupational Exposure/adverse effects , Plant Preparations/adverse effects , Plantago/adverse effects , Rhinitis, Allergic/chemically induced , Adult , Blotting, Western , Conjunctivitis, Allergic/diagnosis , Conjunctivitis, Allergic/immunology , Drug Hypersensitivity/diagnosis , Drug Industry , Humans , Immunoglobulin E/immunology , Intradermal Tests , Laboratory Personnel , Male , Occupational Diseases/diagnosis , Plant Preparations/immunology , Plantago/immunology , Rhinitis, Allergic/diagnosis , Rhinitis, Allergic/immunology
13.
Arch Soc Esp Oftalmol ; 92(10): 499-506, 2017 Oct.
Article in English, Spanish | MEDLINE | ID: mdl-27402451

ABSTRACT

CASES REPORTS: The cases are presented of three women of 22, 36 and 55 years old with bilateral myopic retinochoroidosis. They had unilateral decreased visual acuity, normal bilateral tonometry, and biomicroscopy. Funduscopy showed bilateral and unilateral myopic maculopathy, and Optical Coherence Tomography (OCT) showed a dome shaped macula with neurosensory detachment. Treatment was started with spironolactone and an improvement by OCT was shown in all cases. DISCUSSION: The etiopathogenic mechanism of the dome shaped macula is discussed. OCT demonstrated to be the fundamental test in the follow-up of this condition. After the evidence shown, initial treatment with spironolactone is suggested.


Subject(s)
Chorioretinitis/etiology , Macula Lutea/pathology , Myopia/etiology , Spironolactone/therapeutic use , Adult , Chorioretinitis/drug therapy , Drug Substitution , Female , Humans , Middle Aged , Myopia/physiopathology , Ranibizumab/therapeutic use , Receptors, Mineralocorticoid/metabolism , Receptors, Vascular Endothelial Growth Factor/therapeutic use , Recombinant Fusion Proteins/therapeutic use , Tomography, Optical Coherence , Young Adult
14.
Nutr Metab Cardiovasc Dis ; 26(6): 541-8, 2016 06.
Article in English | MEDLINE | ID: mdl-27174584

ABSTRACT

BACKGROUND AND AIM: In adults, there is some evidence that improving diet reduces blood pressure (BP) and the subsequent risk of cardiovascular diseases (CVDs). However, studies that analyse this association in adolescents are still scarce. The objective of the present study was to examine the associations between heart rate, systolic (SBP), diastolic (DBP) and mean arterial blood pressure (MAP) among European adolescents and usual intake of vegetables, fruits, dairy products, meat, fish, high-sugar foods and savoury snacks. METHODS AND RESULTS: In total, 2283 adolescents from the HELENA-study (12.5-17.5 years old; 1253 girls) were included. Dietary intake was assessed using two computerized 24-hour dietary recalls. Age, sex, body mass index, maternal educational level, physical activity and Tanner stage were considered as confounders. Associations were examined by mixed model analysis stratified by sex. Tests for trend were assessed by tertiles of intake while controlling for the aforementioned confounders. Dairy products and fish intake were negatively associated with BP and heart rate. Significant decreasing trends were observed for heart rate and BP across tertiles of dairy products, fish intake and high-sugar foods intake (p < 0.05). Significant increasing trends were observed for SBP and MAP across tertiles of savoury snack intake (p < 0.05). CONCLUSION: Significant but small inverse associations between fish and dairy products consumption with blood pressure and heart rate have been found in European adolescents. Dietary intervention studies are needed to explore these associations in the context of the modification of several risk factors for the prevention of cardiovascular diseases.


Subject(s)
Blood Pressure , Cardiovascular Diseases/prevention & control , Diet, Healthy , Feeding Behavior , Heart Rate , Adolescent , Adolescent Nutritional Physiological Phenomena , Age Factors , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/physiopathology , Cross-Sectional Studies , Dairy Products , Diet Records , Dietary Sucrose/adverse effects , Europe/epidemiology , Female , Fruit , Humans , Male , Meat , Nutritional Status , Protective Factors , Risk Factors , Seafood , Snacks , Vegetables
15.
Arch Soc Esp Oftalmol ; 91(12): 599-603, 2016 Dec.
Article in English, Spanish | MEDLINE | ID: mdl-27017536

ABSTRACT

CASE REPORT: Two cases are presented of patients with chronic diffuse epitheliopathy (CDE) that showed a favourable response when treated with spironolactone. The first patient had regions of neurosensory detachment (DNS) and the second, multiple DNS, secondary intra-retinal cysts and retinal pigment epithelium detachment. DISCUSSION: After treatment with spironolactone, both patients showed a visual acuity improvement and structural changes (reduced neurosensory retinal detachment and cystoid degeneration). Aldosterone receptor agonists (ARA) used for persistent forms of chronic central serous chorioretinopathy show encouraging results and could represent a therapeutic alternative for CDE.


Subject(s)
Mineralocorticoid Receptor Antagonists/therapeutic use , Retinal Detachment/drug therapy , Spironolactone/therapeutic use , Humans , Male , Middle Aged
17.
Arch Soc Esp Oftalmol ; 90(12): 578-81, 2015 Dec.
Article in English, Spanish | MEDLINE | ID: mdl-26255074

ABSTRACT

CASE REPORT: 78 year-old female patient being investigated for a left orbital pseudotumour of 17 days onset. She had proptosis, pain, with no limitation of eye movements, periorbital oedema, and upper eyelid ptosis, compatible with an orbital pseudotumour. The MRI showed an upper outer left orbital mass adjacent to the side of eyeball and an increase in soft tissue at the level of lacrimal gland. The histopathology study of an eyelid lesion demonstrated the presence of non-caseating granulomas. DISCUSSION: A definitive diagnosis of orbital sarcoidosis was made. Oral treatment with corticosteroids and methotrexate achieved gradual control of the disease.


Subject(s)
Eyelid Diseases/etiology , Magnetic Resonance Imaging , Orbital Pseudotumor/etiology , Sarcoidosis/complications , Adrenal Cortex Hormones/therapeutic use , Aged , Biopsy , Drug Therapy, Combination , Eyelid Diseases/diagnosis , Eyelid Diseases/drug therapy , Female , Granuloma/diagnosis , Granuloma/drug therapy , Granuloma/etiology , Humans , Immunosuppressive Agents/therapeutic use , Methotrexate/therapeutic use , Orbital Pseudotumor/drug therapy , Remission Induction , Sarcoidosis/diagnosis , Sarcoidosis/drug therapy
18.
Arch. Soc. Esp. Oftalmol ; 90(1): 14-21, ene. 2015. tab, graf, ilus
Article in Spanish | IBECS | ID: ibc-136346

ABSTRACT

OBJETIVO: Analizar el beneficio coste-efectividad del implante intravítreo de dexametasona (Ozurdex®, Allergan, Irvine, CA, EE. UU.) en sus aplicaciones clínicamente relevantes. MATERIAL Y MÉTODOS: Un total de 88 ojos de 86 pacientes con edema macular de > 300 μm medido mediante tomografía de coherencia óptica (Zeiss Cirrus, Dublín, CA, EE. UU.) fueron incluidos en este trabajo retrospectivo de 2 años, con un seguimiento mínimo de 6 meses. Se incluyeron 3 grupos de pacientes: el grupo 1 con edema macular en oclusión venosa retiniana, el grupo 2 con uveítis posterior no infecciosa y el grupo 3 con edema macular diabético, estando este fuera de indicación pero avalado por la literatura médica. Antes del implante y los días 1, 30, 60, 90 y 180 se evaluó la agudeza visual corregida (Snellen), espesor retiniano central, presión intraocular y biomicroscopia. Los análisis de coste-beneficio se tabularon por línea de visión ganada, comparando las principales alternativas terapéuticas, y se valoró el perfil de seguridad del implante intravítreo de dexametasona (Ozurdex®; Allergan, Irvine, CA, EE. UU.). RESULTADOS: Los resultados de este estudio no difirieron de los publicados por otros, en términos de mejoría de la agudeza visual en el 63,3% y del espesor macular central en el 97%. En los casos de recidiva, se produjo a los 120 días de media; la necesidad de retratamiento fue del 40,9%. Entre los efectos secundarios, el incremento de presión intraocular > 23 mm Hg se produjo en el 29,54%, controlándose con tratamiento tópico, excepto un 1,13% de los casos que requirieron tratamiento quirúrgico. El desarrollo de catarata fue del 44,7%, requiriendo cirugía un 10,6%. Los resultados del tratamiento mostraron una menor necesidad en la frecuencia del uso de Ozurdex® frente a otros tratamientos para el control de la enfermedad, convirtiéndose en una opción que permite el ahorro de costes. DISCUSIÓN: Los análisis coste-efectividad son clínicamente relevantes cuando se aplican estrategias terapéuticas en pacientes con edema macular. El implante de dexametasona intravítrea es una opción terapéutica segura y eficiente


OBJECTIVE: To analyze the cost-effectiveness and benefits of a dexamethasone intravitreal implant (Ozurdex®, Allergan, Irvine, CA, USA.) in its clinically relevant applications. MATERIAL AND METHODS: A total of 88 eyes of 86 patients with macular edema of > 300 μm measured by optical coherence tomography (Cirrus Zeiss, Dublin, CA, USA) were included in this two-year retrospective study, with a minimum of 6 months follow-up. The patients were divide into 3 groups: group 1 with macular edema in retinal vein occlusion, group 2 with non-infectious posterior uveitis, and group 3 with diabetic macular edema. The treatment was off-label but supported by the literature. Before implantation, and on days 1, 30, 60, 90 and 180, corrected visual acuity (Snellen), central retinal thickness, intraocular pressure and biomicroscopy were evaluated. The cost-benefit analysis was tabulated by line of visual acuity gained, comparing the main therapeutic alternatives and assessment of the safety profile of the dexamethasone intravitreal implant (Ozurdex®, Allergan, Irvine, CA, USA). RESULTS: The results of this study did not differ from the published studies, in terms of visual acuity improvement in 63.3% of cases, and with central macular thickness improvement in 97% of cases. There were relapses, which occurred after 120 days on average, and the need for retreatment was 40.9%. Increased intraocular pressure >23 mm Hg was among the side effects in 29.54%, and was controlled with topical treatment, except in 1.13% requiring surgical treatment. The development of cataract was 44.7%, and 10.6% required surgery. Treatment results showed less frequent use of Ozurdex® than other treatments for disease control, being a cost saving option. DISCUSSION: Cost-effectiveness analyses are clinically relevant when applying treatment strategies in patients with macular edema. Dexamethasone intravitreal implant appears to be a safe and efficient therapy


Subject(s)
Humans , Male , Female , Macular Edema/chemically induced , Macular Edema/metabolism , Prostheses and Implants , Prostheses and Implants , Retinal Vein Occlusion/chemically induced , Retinal Vein Occlusion/metabolism , Diabetic Retinopathy/metabolism , Diabetic Retinopathy/pathology , Pharmaceutical Preparations , Macular Edema/diagnosis , Macular Edema/surgery , Prostheses and Implants/economics , Prostheses and Implants/supply & distribution , Retinal Vein Occlusion/diagnosis , Retinal Vein Occlusion/prevention & control , Diabetic Retinopathy/complications , Diabetic Retinopathy/prevention & control , Pharmaceutical Preparations/supply & distribution , Retrospective Studies
19.
Arch Soc Esp Oftalmol ; 90(1): 14-21, 2015 Jan.
Article in Spanish | MEDLINE | ID: mdl-25443181

ABSTRACT

OBJECTIVE: To analyze the cost-effectiveness and benefits of a dexamethasone intravitreal implant (Ozurdex®, Allergan, Irvine, CA, USA.) in its clinically relevant applications. MATERIAL AND METHODS: A total of 88 eyes of 86 patients with macular edema of > 300 µm measured by optical coherence tomography (Cirrus Zeiss, Dublin, CA, USA) were included in this two-year retrospective study, with a minimum of 6 months follow-up. The patients were divide into 3 groups: group 1 with macular edema in retinal vein occlusion, group 2 with non-infectious posterior uveitis, and group 3 with diabetic macular edema. The treatment was off-label but supported by the literature. Before implantation, and on days 1, 30, 60, 90 and 180, corrected visual acuity (Snellen), central retinal thickness, intraocular pressure and biomicroscopy were evaluated. The cost-benefit analysis was tabulated by line of visual acuity gained, comparing the main therapeutic alternatives and assessment of the safety profile of the dexamethasone intravitreal implant (Ozurdex®, Allergan, Irvine, CA, USA). RESULTS: The results of this study did not differ from the published studies, in terms of visual acuity improvement in 63.3% of cases, and with central macular thickness improvement in 97% of cases. There were relapses, which occurred after 120 days on average, and the need for retreatment was 40.9%. Increased intraocular pressure >23 mm Hg was among the side effects in 29.54%, and was controlled with topical treatment, except in 1.13% requiring surgical treatment. The development of cataract was 44.7%, and 10.6% required surgery. Treatment results showed less frequent use of Ozurdex® than other treatments for disease control, being a cost saving option. DISCUSSION: Cost-effectiveness analyses are clinically relevant when applying treatment strategies in patients with macular edema. Dexamethasone intravitreal implant appears to be a safe and efficient therapy.


Subject(s)
Anti-Inflammatory Agents/economics , Dexamethasone/economics , Macular Edema/economics , Aged , Angiogenesis Inhibitors/economics , Angiogenesis Inhibitors/therapeutic use , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Antibodies, Monoclonal/economics , Antibodies, Monoclonal/therapeutic use , Cataract/chemically induced , Cost-Benefit Analysis , Dexamethasone/administration & dosage , Dexamethasone/therapeutic use , Diabetic Retinopathy/drug therapy , Drug Implants , Female , Humans , Macular Edema/drug therapy , Macular Edema/surgery , Male , Middle Aged , Off-Label Use , Recurrence , Retinal Vein Occlusion/complications , Retinal Vein Occlusion/drug therapy , Retrospective Studies , Tomography, Optical Coherence , Treatment Outcome , Triamcinolone Acetonide/economics , Triamcinolone Acetonide/therapeutic use , Uveitis, Posterior/complications , Uveitis, Posterior/drug therapy , Visual Acuity , Vitrectomy , Vitreous Body
20.
Hernia ; 19(5): 771-4, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25480125

ABSTRACT

PURPOSE: Self-gripping meshes have been developed to avoid fixing sutures during inguinal hernia repair. Operative time is shorter when using a self-gripping mesh than with conventional Lichtenstein repair. However, these meshes can be difficult to handle because they fix to undesired structures. The aim of this report is to describe a new technique to avoid this problem. TECHNIQUE: Inguinal hernia dissection is made as usual. Once dissection is finished, a Parietex ProGrip(®) (Covidien, Dublin, Ireland) flat sheet mesh is cut depending on the size needed. A small split is made between the lower and medium third of the mesh to mark where the split for the spermatic cord will be. Using this mark, the upper third of the mesh is folded over the medium third, hiding the microgrips that make this a self-gripping mesh. In this way, only the lower third of the mesh has the microgrips exposed and the mesh can be fixed to the pubic bone and inguinal ligament without fixation to undesired structures. Once the lower third of the mesh is fixed, the split for the spermatic cord is completed and the upper part of the mesh is passed below the spermatic cord. Then, the mesh is unfolded to expose the microgrips again and the medium and upper third of the mesh are descended to its final position. CONCLUSION: This proposed technique for inguinal hernia repair with self-gripping mesh makes the surgery easier, avoiding mesh fixation to undesired structures.


Subject(s)
Hernia, Inguinal/surgery , Herniorrhaphy/instrumentation , Surgical Mesh , Herniorrhaphy/methods , Humans , Tissue Adhesives
SELECTION OF CITATIONS
SEARCH DETAIL
...